Search Results - "Amass, Leslie"

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy by Schmidt, Hartmut H., Waddington‐Cruz, Márcia, Botteman, Marc F., Carter, John A., Chopra, Avijeet S., Hopps, Markay, Stewart, Michelle, Fallet, Shari, Amass, Leslie

“…ABSTRACT Introduction: This study sought to estimate the global prevalence of transthyretin familial amyloid polyneuropathy (ATTR‐FAP). Methods: Prevalence…”
Get full text

"Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy by Conceição, Isabel, González-Duarte, Alejandra, Obici, Laura, Schmidt, Hartmut H.-J., Simoneau, Damien, Ong, Moh-Lim, Amass, Leslie

“…© 2015 The Authors. Journal of the Peripheral Nervous System published by Wiley Periodicals, Inc. on behalf of Peripheral Nerve Society. This is an open access…”
Get full text

Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series by Waddington-Cruz, Márcia, Schmidt, Hartmut, Botteman, Marc F, Carter, John A, Stewart, Michelle, Hopps, Markay, Fallet, Shari, Amass, Leslie

“…We describe 542 cases of symptomatic hereditary transthyretin amyloid polyneuropathy (ATTR-PN) identified through a review of the literature published between…”
Get full text

Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years by Barroso, Fabio A., Judge, Daniel P., Ebede, Ben, Li, Huihua, Stewart, Michelle, Amass, Leslie, Sultan, Marla B.

“…Background: The objective of the present study was to evaluate the long-term safety and efficacy of tafamidis in treating hereditary transthyretin amyloid…”
Get full text

Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update by Dispenzieri, Angela, Coelho, Teresa, Conceição, Isabel, Waddington-Cruz, Márcia, Wixner, Jonas, Kristen, Arnt V, Rapezzi, Claudio, Planté-Bordeneuve, Violaine, Gonzalez-Moreno, Juan, Maurer, Mathew S, Grogan, Martha, Chapman, Doug, Amass, Leslie, Pavia, Pablo Garcia, Tarnev, Ivaylo, Costello, Jose Gonzalez, Briseno, Maria Alejandra Gonzalez Duarte, Schmidt, Hartmut, Drachman, Brian, Barroso, Fabio Adrian, Yamashita, Taro, Lairez, Olivier, Sekijima, Yoshiki, Vita, Giuseppe, Jeon, Eun-Seok, Hanna, Mazen, Slosky, David, Luigetti, Marco, LoRusso, Samantha, Beamud, Francisco Munoz, Adams, David, Moelgaard, Henning, Press, Rayomand, Cirami, Calogero Lino, Nienhuis, Hans, Plana, Josep Maria Campistol, Inamo, Jocelyn, Jacoby, Daniel, Emdin, Michele, Quan, Dianna, Hummel, Scott, Witteles, Ronald, Dori, Amir, Shah, Sanjiv, Lenihan, Daniel, Azevedo, Olga, Murali, Srinivas, Zivkovic, Sasa, Low, Soon Chai, Nativi-Nicolau, Jose, Fine, Nowell, Tallaj, Jose, Tschoepe, Carsten, Torrón, Roberto Fernandéz, Polydefkis, Michael, Merlini, Giampaolo, Badelita, Sorina, Gottlieb, Stephen, Tauras, James, Correia, Edileide Barros, Ventura, Hector, Gess, Burkhard, Darstein, Felix, Oh, Jeeyoung, Marburger, Tessa, Van Cleemput, Johan, Salutto, Valeria Lujan, Parman, Yesim, Chao, Chi-Chao, Sarswat, Nitasha, Mueller, Christopher, Steidley, David, Ralph, Jeffrey, Warner, Alberta, Cotts, William, Hoffman, James, Rugiero, Marcelo, Misawa, Sonoko, Blanco, Jose Luis Munoz, Davila, Lucia Galan, Sadeh, Menachem, Luo, Jin, Kyriakides, Theodoros, Wang, Annabel, Kaufmann, Horacio

“…Abstract Background Transthyretin amyloidosis (ATTR amyloidosis) is a rare, life-threatening disease caused by the accumulation of variant or wild-type (ATTRwt…”
Get full text

Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS) by Gentile, Luca, Diemberger, Igor, Plante-Bordeneuve, Violaine, Mazzeo, Anna, Dori, Amir, Luigetti, Marco, Di Paolantonio, Andrea, Dispenzieri, Angela, Grogan, Martha, Waddington Cruz, Márcia, Adams, David, Inamo, Jocelyn, Kristen, Arnt V, Lino Cirami, Calogero, Chapman, Doug, Gupta, Pritam, Glass, Oliver, Amass, Leslie

“…Transthyretin amyloidosis (ATTR amyloidosis) is a progressive, multi-systemic disease with wild-type (ATTRwt) and hereditary (ATTRv) forms. Over 130 variants…”
Get full text

A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS) by Gentile, Luca, Coelho, Teresa, Dispenzieri, Angela, Conceição, Isabel, Waddington-Cruz, Márcia, Kristen, Arnt, Wixner, Jonas, Diemberger, Igor, Gonzalez-Moreno, Juan, Cariou, Eve, Maurer, Mathew S, Planté-Bordeneuve, Violaine, Garcia-Pavia, Pablo, Tournev, Ivailo, Gonzalez-Costello, Jose, Duarte, Alejandra Gonzalez, Grogan, Martha, Mazzeo, Anna, Chapman, Doug, Gupta, Pritam, Glass, Oliver, Amass, Leslie

“…Abstract Background Transthyretin amyloidosis (ATTR amyloidosis) is a progressive, multisystemic, life-threatening disease resulting from the deposition of…”
Get full text

Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS) by Waddington‐Cruz, Márcia, Ando, Yukio, Amass, Leslie, Kiszko, Jan, Chapman, Doug, Sekijima, Yoshiki

“…Patients with transthyretin amyloid polyneuropathy (ATTR‐PN) show decreased motor and sensory nerve amplitudes and conduction. Electrophysiological changes…”
Get full text

Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy by Amass, Leslie, Li, Huihua, Gundapaneni, Balarama K, Schwartz, Jeffrey H, Keohane, Denis J

“…Emerging evidence suggests that several factors can impact disease progression in transthyretin amyloid polyneuropathy (ATTR-PN). The present analysis used…”
Get full text

Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy by Schmidt, Hartmut H.-J., Barroso, Fabio, González-Duarte, Alejandra, Conceição, Isabel, Obici, Laura, Keohane, Denis, Amass, Leslie

“…© 2016 The Authors Muscle & Nerve Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons…”
Get full text

Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Variant Transthyretin Amyloid Cardiomyopathy by Streicher, Nicholas, Amass, Leslie, Wang, Rong, Stephens, Jennifer M., LeMasters, Traci, Raina, Rutika, Merrill, Emma, Sheikh, Farooq H.

“…Introduction Transthyretin amyloidosis (ATTR) is a progressive, heterogeneous rare disease manifesting as ATTR polyneuropathy (ATTR-PN), ATTR cardiomyopathy…”
Get full text

Buprenorphine Use: The International Experience by Carrieri, Maria Patrizia, Amass, Leslie, Lucas, Gregory M., Vlahov, David, Wodak, Alex, Woody, George E.

“…The confluence of the heroin injection epidemic and the human immunodeficiency virus (HIV) infection epidemic has increased the call for expanded access to…”
Get full text

Age- and Sex-Related Differences in Patients With Wild-Type Transthyretin Amyloidosis by Mora-Ayestaran, Nerea, Dispenzieri, Angela, Kristen, Arnt V., Maurer, Mathew S., Diemberger, Igor, Drachman, Brian M., Grogan, Martha, Gupta, Pritam, Glass, Oliver, Amass, Leslie, Garcia-Pavia, Pablo, Emdin, Michele, Hanna, Mazen, Azevedo, Olga, Lino Cirami, Calogero, Gonzalez Costello, Jose, Slosky, David, Moelgaard, Henning, Nativi Nicolau, Jose, Hummel, Scott, Jeon, Eun-Seok, Fine, Nowell, Murali, Srinivas, Miller, Edward, Shah, Sanjiv, Witteles, Ronald, Waddington-Cruz, Marcia, Lenihan, Daniel, Sekijima, Yoshiki, Van Cleemput, Johan, Correia, Edileide de Barros, Cariou, Eve, Quan, Dianna, Freimer, Miriam, Steidley, David, Hüsing-Kabar, Anna, Plante-Bordeneuve, Violaine, Nienhuis, Hans, Wixner, Jonas, Ralph, Jeffrey, Ventura, Hector, Zivkovic, Sasa, Delgado, Diego, Fernandéz Torrón, Roberto, Gottlieb, Stephen, Cotts, William, Tallaj, Jose, Brunkhorst, Robert, Polydefkis, Michael, Mueller, Christopher, Tschoepe, Carsten, Gonzalez Moreno, Juan, Sarswat, Nitasha, Luo, Jin, Tauras, James, Warner, Alberta

“…Wild-type transthyretin amyloidosis (ATTRwt amyloidosis) is primarily diagnosed in elderly men but diagnoses in younger patients and women have recently…”
Get full text

Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey by González-Moreno, Juan, Dispenzieri, Angela, Grogan, Martha, Coelho, Teresa, Tournev, Ivailo, Waddington-Cruz, Márcia, Wixner, Jonas, Diemberger, Igor, Garcia-Pavia, Pablo, Chapman, Doug, Gupta, Pritam, Glass, Oliver, Amass, Leslie

“…Introduction Transthyretin amyloidosis (ATTR amyloidosis) is primarily associated with a cardiac or neurologic phenotype, but a mixed phenotype is increasingly…”
Get full text

Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis by Caponetti, Angelo Giuseppe, Rapezzi, Claudio, Gagliardi, Christian, Milandri, Agnese, Dispenzieri, Angela, Kristen, Arnt V., Wixner, Jonas, Maurer, Mathew S., Garcia-Pavia, Pablo, Tournev, Ivailo, Planté-Bordeneuve, Violaine, Chapman, Douglass, Amass, Leslie, van Cleemput, Johan, Waddington-Cruz, Marcia, Schmidt, Hartmut, Dillmann, Klaus-Ulrich, Mølgaard, Henning, Moreno, Juan Gonzalez, Costello, Jose Gonzalez, Beamud, Francisco Munoz, Davila, Lucia Galan, Adams, David, Inamo, Jocelyn, Lairez, Olivier, Vita, Giuseppe, Merlini, Giampaolo, Cirami, Calogero Lino, Luigetti, Marco, Emdin, Michele, Sekijima, Yoshiki, Jeon, Eun-Seok, Oh, Jeeyoung, Gonzalez Duarte Briseno, Maria Alejandra, Nienhuis, Hans, Coelho, Teresa, Conceicao, Isabel, Azevedo, Olga, Badelita, Sorina, Press, Rayomand, Parman, Yesim, Shah, Sanjiv, Quan, Dianna, Marburger, Tessa, Polydefkis, Michael, Witteles, Ronald, Gottlieb, Stephen, Sarswat, Nitasha, Drachman, Brian, Steidley, David, Hummel, Scott, Slosky, David, Jacoby, Daniel, Nativi-Nicolau, Jose, Tauras, James, Zivkovic, Sasa, Tallaj, Jose, Lenihan, Daniel

“…Because patients with ATTRv cardiomyopathy are more likely to be male, this analysis aimed to increase information on associations between sex and genotype,…”
Get full text

Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy by González‐Duarte, Alejandra, Conceição, Isabel, Amass, Leslie, Botteman, Marc F., Carter, John A., Stewart, Michelle

“…Introduction Hereditary (variant) transthyretin amyloidosis (ATTRv) with polyneuropathy (ATTR-PN) is a rare genetic disorder that causes progressive autonomic…”
Get full text

Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial by Keohane, Denis, Schwartz, Jeffrey, Gundapaneni, Balarama, Stewart, Michelle, Amass, Leslie

“…Background: Tafamidis, a non-NSAID highly specific transthyretin stabilizer, delayed neurologic disease progression as measured by Neuropathy Impairment…”
Get full text

Contingency management among homeless, out-of-treatment men who have sex with men by Reback, Cathy J., Ph.D, Peck, James A., Psy.D, Dierst-Davies, Rhodri, M.P.H, Nuno, Miriam, Ph.D, Kamien, Jonathan B., Ph.D, Amass, Leslie, Ph.D

“…Abstract Homeless men who have sex with men are a particularly vulnerable population with high rates of substance dependence, psychiatric disorders, and HIV…”
Get full text

Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy by Waddington Cruz, Márcia, Amass, Leslie, Keohane, Denis, Schwartz, Jeffrey, Li, Huihua, Gundapaneni, Balarama

“…Transthyretin hereditary amyloid polyneuropathy, also traditionally known as transthyretin familial amyloid polyneuropathy (ATTR-FAP), is a rare, relentless,…”
Get full text

Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS) by GARCIA-PAVIA, PABLO, KRISTEN, ARNT V., DRACHMAN, BRIAN, CARLSSON, MARTIN, AMASS, LESLIE, ANGELI, FRANCA STEDILE, MAURER, MATHEW S.

“…•Overall survival was examined in real-world patients with ATTR-CM.•Survival rates were higher than in ATTR-ACT and consistent with more recent reports.•These…”
Get full text